Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 | +$1.24B | |
| 2 | +$1.15B | |
| 3 | +$813M | |
| 4 |
Adobe
ADBE
|
+$555M |
| 5 |
Fidelity National Information Services
FIS
|
+$516M |
Top Sells
| 1 | +$994M | |
| 2 | +$874M | |
| 3 | +$841M | |
| 4 |
Nutrien
NTR
|
+$587M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$399M |
Sector Composition
| 1 | Healthcare | 23.72% |
| 2 | Financials | 18.28% |
| 3 | Industrials | 12.84% |
| 4 | Technology | 11.99% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class A
GOOGL
$3.86T
| $2.76B | 1.49% |
11,338,777
+63,559
|
|
||
27
Cigna
CI
$74.1B
| $2.68B | 1.45% |
9,305,225
+354,615
|
|
||
28
Capital One
COF
$139B
| $2.57B | 1.39% |
12,107,917
-748,539
|
|
||
29
Regeneron Pharmaceuticals
REGN
$82B
| $2.56B | 1.38% |
4,550,845
+724,562
|
|
||
30
Air Products & Chemicals
APD
$58.1B
| $2.46B | 1.33% |
9,004,892
+183,492
|
|
||
31
Zimmer Biomet
ZBH
$19.3B
| $2.29B | 1.23% |
23,216,173
+1,118,710
|
|
||
32
International Flavors & Fragrances
IFF
$17.8B
| $2.28B | 1.23% |
36,972,638
+1,925,251
|
|
||
33
AB InBev
BUD
$120B
| $2.18B | 1.18% |
36,546,221
-1,931,321
|
|
||
34
Baker Hughes
BKR
$49.5B
| $2.15B | 1.16% |
44,053,488
-529,325
|
|
||
35
Fortive
FTV
$17B
| $2.09B | 1.13% |
42,595,794
+9,422,189
|
|
||
36
GE HealthCare
GEHC
$36.4B
| $2.07B | 1.12% |
27,517,311
+3,949,361
|
|
||
37
Alibaba
BABA
$375B
| $1.96B | 1.06% |
10,975,370
+11,100
|
|
||
38
GE Aerospace
GE
$315B
| $1.89B | 1.02% |
6,271,622
-2,794,189
|
|
||
39
SBA Communications
SBAC
$20.7B
| $1.87B | 1.01% |
9,667,297
+1,058,803
|
|
||
40
Sun Communities
SUI
$15.9B
| $1.87B | 1.01% |
14,480,815
+282,055
|
|
||
41
Goldman Sachs
GS
$248B
| $1.76B | 0.95% |
2,208,625
-1,097,949
|
|
||
42
UBS Group
UBS
$121B
| $1.75B | 0.95% |
42,641,442
-2,994,500
|
|
||
43
Elanco Animal Health
ELAN
$11.6B
| $1.67B | 0.9% |
82,759,837
-135,395
|
|
||
44
Coupang
CPNG
$51.4B
| $1.51B | 0.82% |
46,947,720
+333,200
|
|
||
45
Avantor
AVTR
$8B
| $1.47B | 0.79% |
117,746,888
+313,404
|
|
||
46
Dominion Energy
D
$53.6B
| $1.39B | 0.75% |
22,780,033
-145,215
|
|
||
47
Haleon
HLN
$43.5B
| $1.38B | 0.75% |
154,384,622
-1,087,377
|
|
||
48
Novartis
NVS
$250B
| $1.36B | 0.73% |
10,585,145
-62,484
|
|
||
49
Baxter International
BAX
$9.63B
| $1.31B | 0.71% |
57,396,370
+5,274,750
|
|
||
50
Credicorp
BAP
$20.4B
| $1.3B | 0.7% |
4,899,715
-247,665
|
|